Search results
Dilip Shanghvi (born 1 October 1955) is an Indian billionaire businessman. As the founder of Sun Pharmaceuticals, he is one of the country's richest people. The Government of India awarded him the civilian honor of the Padma Shri in 2016. India Today magazine ranked him 8th in India's most powerful people of 2017 list.
1 day ago · Dilip Shanghvi is the chairman and managing director of Sun Pharma. He wrested control of Israel-based Taro Pharma after a bitter three-year battle with Taro's owners.
Dilip Shanghvi is the Founder and Chairman and Managing Director of Sun Pharmaceutical Industries Limited. He is also the Chairman of Sun Pharma Advanced Research Company Ltd., which is engaged in R&D of new innovative drugs and delivery technologies.
Oct 11, 2023 · Son of a pharma distributor, Dilip Shanghvi borrowed $200 from his father to start Sun Pharmaceutical Industries in 1983 to make psychiatric drugs. The company...
May 8, 2024 · Dilip Shanghvi, Indian business executive who was the founder (1983) of Sun Pharmaceutical Industries Ltd., which became the largest pharmaceutical company in India and one of the largest generic-drug producers in the world. Learn more about Shanghvi’s life and career.
Oct 4, 2021 · Founder and managing director Dilip Shanghvi, known for his poise, has steered India’s largest pharma company past USD4 billion in annual revenue. The expectations are high. At roughly USD26 billion, Sun Pharma tops in market capitalisation among its pharmaceutical peers in the country.
2 days ago · Overview. Shanghvi is the founder of Sun Pharmaceutical Industries, a generic drugmaker with revenue of $5.4 billion in the year to March 31, 2023. The Mumbai-based company has more than 40...
Jul 11, 2023 · Under Dilip Shanghvi, Sun Pharmaceutical Industries Limited, India’s largest pharma company, is building additional engines of growth with an eye on the future, especially the specialty...
Dec 22, 2010 · Sun Pharma Chairman and Managing Director Dilip Shanghvi achieved a milestone he had set for himself — to become the largest Indian generic drug company in the US.
Discover The Investment Super Power That Is Dilip Shanghvi. Learn How This Pharmaceutical Giant Came From A Humble Start And Is Now Reshaping The Future Of Pharma In India.
